Bellrose Capital

Bellrose Capital FCF Margin

Free Cash Flow Margin of Bellrose Capital (BELR) as of Nov 2, 2026.

FCF Margin

-

Last updated:

Free Cash Flow Margin of Bellrose Capital is 2026 - . Free Cash Flow Margin of Bellrose Capital was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bellrose Capital Stock analysis

What does Bellrose Capital do? Founder and CEO Susan Johnson founded Deep Blue Inc in 2004 with the aim of developing powerful and effective technologies for the healthcare industry. The company is based in Los Angeles and employs over 100 employees worldwide. The story of Deep Blue Inc began with the development of software for medical image processing. However, in recent years the company has evolved into a comprehensive provider of health technology, offering a wide range of products and services for the healthcare industry. Deep Blue Inc operates in three main areas: medical image processing, clinical decision support, and digital health records. In the field of medical image processing, the company develops software solutions for the analysis of medical images, which assist doctors in diagnosing and monitoring diseases. In the field of clinical decision support, Deep Blue Inc relies on artificial intelligence and machine learning to develop expert systems and decision support tools for medical professionals, with the aim of improving the quality of patient care. Deep Blue Inc also offers a digital health record that allows for the management and sharing of health data. Doctors and patients can collectively manage data such as diagnoses, medication plans, and treatment outcomes. Deep Blue Inc's products also include mobile apps for patients who want to monitor and manage their health. The company also provides training for medical personnel to ensure they can effectively utilize Deep Blue Inc's technologies and products. Deep Blue Inc has formed partnerships with leading healthcare organizations and companies worldwide to implement and market its technologies and products. Partners include hospitals, healthcare systems, government institutions, and private companies. Deep Blue Inc's business model is based on the development of innovative technologies for the healthcare industry and collaboration with partners and customers to implement and market these technologies. The company generates revenue through the sale of products and services, as well as through licensing fees and partnership agreements. In recent years, Deep Blue Inc has received several awards and recognitions for its innovative technologies and services in the healthcare industry. The company is proud to contribute to improving patient care and lowering healthcare costs. Overall, Deep Blue Inc has become a significant player in the health technology market. The company is committed to continuing to improve its technologies and products, and to collaborating with partners and customers worldwide to improve healthcare and reduce healthcare costs. Bellrose Capital is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bellrose Capital stock

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Bellrose Capital since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Bellrose Capital with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bellrose Capital

All Key Metrics — Bellrose Capital